Expenditure on research and development (R&D) performed by UK businesses was £50bn in 2023 an increase of £1.4bn since 2022 (2.9%) according to the data for 2023 from the Office for National Statistics’ (ONS) annual business enterprise research and development (BERD) survey.
The pharmaceuticals product group made the largest contribution (£8.7bn) to the total of business R&D performed in 2023 (17.4% of the total performed).
London had the largest regional value of business R&D performed in 2023 at £11bn (22%); this was followed by the east of England at £9.7bn (19.5%) and the south east at £8.5bn (16.9%).
When measuring the value of R&D performed by industry the scientific R&D industry performed the most at £12.7bn (25.3%).
Estimates in the ONS release have been compiled based on the new sampling and results methods that were introduced for the 2022 survey. They are...
Please reach out to customer services at +44 (0) 330 161 1234 or 'customer.services@lexisnexis.co.uk' for further assistance.